GENinCode Plc (LON:GENI – Get Free Report) shares dropped 6.1% on Wednesday . The stock traded as low as GBX 2.20 and last traded at GBX 2.30. Approximately 967,221 shares traded hands during mid-day trading, an increase of 63% from the average daily volume of 591,585 shares. The stock had previously closed at GBX 2.45.
GENinCode Stock Performance
The stock has a 50-day simple moving average of GBX 2.54 and a 200-day simple moving average of GBX 2.47. The stock has a market cap of £6.02 million, a PE ratio of -0.89 and a beta of 0.66. The company has a debt-to-equity ratio of 9.28, a current ratio of 2.60 and a quick ratio of 15.89.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Read More
- Five stocks we like better than GENinCode
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- First Time Since 2007: All Warnings Active
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
